Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $2.91 million. The enterprise value is -$4.24 million.
Important Dates
The last earnings date was Thursday, February 19, 2026, before market open.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 1.15 million shares outstanding. The number of shares has increased by 831.86% in one year.
| Current Share Class | 1.15M |
| Shares Outstanding | 1.15M |
| Shares Change (YoY) | +831.86% |
| Shares Change (QoQ) | +39.84% |
| Owned by Insiders (%) | 4.58% |
| Owned by Institutions (%) | 7.08% |
| Float | 1.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.06 |
| P/TBV Ratio | 0.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.09
| Current Ratio | 8.09 |
| Quick Ratio | 7.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -388.63 |
Financial Efficiency
Return on equity (ROE) is -74.29% and return on invested capital (ROIC) is -43.55%.
| Return on Equity (ROE) | -74.29% |
| Return on Assets (ROA) | -34.44% |
| Return on Invested Capital (ROIC) | -43.55% |
| Return on Capital Employed (ROCE) | -34.98% |
| Weighted Average Cost of Capital (WACC) | 5.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$328,466 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.19% in the last 52 weeks. The beta is 0.32, so PBM's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -96.19% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 19.43 |
| Relative Strength Index (RSI) | 35.47 |
| Average Volume (20 Days) | 475,050 |
Short Selling Information
The latest short interest is 86,725, so 7.56% of the outstanding shares have been sold short.
| Short Interest | 86,725 |
| Short Previous Month | 145,422 |
| Short % of Shares Out | 7.56% |
| Short % of Float | 7.93% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.15M |
| Pretax Income | -3.94M |
| Net Income | -3.94M |
| EBITDA | -4.15M |
| EBIT | -4.15M |
| Earnings Per Share (EPS) | -$34.78 |
Full Income StatementBalance Sheet
The company has $7.15 million in cash and n/a in debt, with a net cash position of $7.15 million or $6.23 per share.
| Cash & Cash Equivalents | 7.15M |
| Total Debt | n/a |
| Net Cash | 7.15M |
| Net Cash Per Share | $6.23 |
| Equity (Book Value) | 11.87M |
| Book Value Per Share | 39.62 |
| Working Capital | 6.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.25 million and capital expenditures -$3,677, giving a free cash flow of -$4.25 million.
| Operating Cash Flow | -4.25M |
| Capital Expenditures | -3,677 |
| Free Cash Flow | -4.25M |
| FCF Per Share | -$3.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
